1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. SUN PHARMACEUTICAL INDUSTRIES LTD.

Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE: 524715

Falling Comet
Download real time

1687.55 35.35 (2.14%)

3.9M NSE+BSE Volume

NSE 11 Apr, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
18S
5W
4O
1T
404,899.8

Market Cap

Market Leader
35.4

PE TTM

Below industry Median
1.2

PEG TTM

PEG TTM is much higher than 1
5.9

Price to Book

Above industry Median
0.6

Beta 1Year

Very Low volatility
Analyst Buy
Emkay retains its 'Buy' call on Sun Pharma, expects a revenue CAGR of 10.2% over FY25-27 See details


Board Meetings - Sun Pharmaceutical Industries Ltd.

The latest board meeting for Sun Pharmaceutical Industries Ltd. took place on 31 Jan 2025, for the purpose of Quarterly Results & Interim Dividend

Share
Ex-date Purpose Notes
31 Jan 2025 Quarterly Results & Interim Dividend -
28 Oct 2024 Quarterly Results -
01 Aug 2024 Quarterly Results -
22 May 2024 Audited Results & Final Dividend -
31 Jan 2024 Quarterly Results & Interim Dividend -
01 Nov 2023 Quarterly Results -
03 Aug 2023 Quarterly Results -
26 May 2023 Audited Results & Final Dividend -
31 Jan 2023 Quarterly Results & Interim Dividend -
01 Nov 2022 Quarterly Results -
29 Jul 2022 Quarterly Results -
30 May 2022 Audited Results & Final Dividend -
31 Jan 2022 Quarterly Results & Interim Dividend -
02 Nov 2021 Quarterly Results -
30 Jul 2021 Quarterly Results -
27 May 2021 Audited Results & Final Dividend -
29 Jan 2021 Quarterly Results -
03 Nov 2020 Quarterly Results -
31 Jul 2020 Quarterly Results -
27 May 2020 Audited Results & Final Dividend -
17 Mar 2020 Buy Back of Shares -
06 Feb 2020 Quarterly Results -
07 Nov 2019 Quarterly Results -
13 Aug 2019 Quarterly Results -
28 May 2019 Audited Results & Dividend -
12 Feb 2019 Quarterly Results -
13 Nov 2018 Quarterly Results -
14 Aug 2018 Quarterly Results -
25 May 2018 Audited Results & Dividend -
14 Feb 2018 Quarterly Results -
14 Nov 2017 Quarterly Results -
26 May 2017 Audited Results & Dividend -
14 Feb 2017 Quarterly Results -
10 Nov 2016 Quarterly Results & Others To consider the proposal for the merger/amalgamation of Ranbaxy Drugs Limited, Vidyut Investments Limited, Gufic Pharma Limited and Sun Pharma Medisales Private Limited.
12 Aug 2016 Quarterly Results -
23 Jun 2016 Buy Back of Equity Shares -
30 May 2016 Audited Results & Dividend -
12 Feb 2016 Quarterly Results -
07 Nov 2015 Quarterly Results -
11 Aug 2015 Quarterly Results & Dividend Consideration of the revised audited annual accounts of the Co for the year ended 31/03/ 2015 after giving the effect to the Scheme of Amalgamation of SPGI into SPIL.
29 May 2015 Audited Results & Amalgamation -
14 Feb 2015 Quarterly Results -
13 Nov 2014 Quarterly Results -
12 Aug 2014 Revised Audited, Qtr Results & Dividend Consider the revised audited annual accounts of the Co. for the year ended March 31, 2014 after giving the effect to the Scheme of Arrangement and Reconstruction between between SPIL and SPGFZE.
29 May 2014 Audited Results -
13 Feb 2014 Quarterly Results -
13 Nov 2013 Quarterly Results -
09 Aug 2013 Quarterly Results -
28 May 2013 Others -
08 Feb 2013 Quarterly Results -
08 Nov 2012 Quarterly Results -
10 Aug 2012 Interim dividend & Others To consider the internal restructuring of the business of the Company with effect from March 31,2012 & to consider declaration of the interim dividend of Rs.4.25 per Share of Re.1 each.
29 May 2012 Audited Results & Dividend -
13 Feb 2012 Quarterly Results -
13 Nov 2011 Quarterly Results -
28 Jul 2011 Quarterly Results -
28 May 2011 Audited Results & Dividend -
31 Jan 2011 Quarterly Results -
30 Oct 2010 Quarterly Results -
24 Sep 2010 Stock split The Board has approved the proposal to sub-divide the nominal value of the Equity Shares of the Company from the nominal value of Rs. 5 each to the nominal value of Re. 1 each.
28 Jul 2010 Quarterly Results -
24 May 2010 Audited Results & Dividend -
29 Jan 2010 Quarterly Results -
28 Oct 2009 Quarterly Results -
29 Jul 2009 Quarterly Results -
30 May 2009 Audited Results & Dividend -
30 Jan 2009 Quarterly Results -
25 Oct 2008 Quarterly Results -
28 Jul 2008 Quarterly Results -
30 May 2008 Audited Results & Dividend -
30 Jan 2008 Quarterly Results -
25 Oct 2007 Quarterly Results & Others To consider payment of interim dividend @ 6% p.a. on outstanding 1,37,40,030 Preference Shares of Re 1/- each on prorata basis for the period from April 01, 2007 to November 01, 2007.
23 Jul 2007 Quarterly Results -
18 May 2007 Audited Results (Revised)
10 Mar 2007 Interim Dividend -
29 Jan 2007 Quarterly Results -
19 Oct 2006 Quarterly Results -
26 Jul 2006 Quarterly Results -
06 Jun 2006 Accounts & Dividend Recommendation of payment of preference share dividend @ 6% p.a. on outstanding Preference Shares for the year ended March 31, 2006.
09 Feb 2006 Demerger inter alia, to consider the proposal for demerger of the Company's Innovative Research & Development (including new drug delivery systems) undertaking to a new company.
30 Jan 2006 Quarterly Results -
28 Oct 2005 Quarterly Results -
18 Aug 2005 Accounts & Dividend -
27 Jul 2005 Quarterly Results -
27 Apr 2005 Quarterly Results -
04 Apr 2005 Acquisition of pharmaceutical business Decided to acquire pharmaceutical business of M J Pharmaceuticals Ltd including its manufacturing unit at Halol, Gujarat along with all its assets and liabilities pertaining to pharmaceutical business
08 Feb 2005 Merger/Amalgamation To consider the proposal for merger / amalgamation of its wholly owned subsidiary companies (1) Bazley Finvest Pvt Ltd, (2) Dhaval Finvest Pvt Ltd and (3) Manish Finvest Pvt Ltd, with the Company.
21 Jan 2005 Quarterly Results -
26 Nov 2004 Interim Dividend & Others Issued US$ 275,000,000 Zero Coupon Foreign Currency Convertible Bonds (FCCB) due 2009 (subject to an increase of up to a further US$ 75,000,000 pursuant to the Option).
21 Oct 2004 Quarterly Results -
31 Jul 2004 Quarterly Results -
21 Apr 2004 Dividend -
08 Apr 2004 Others To consider the issue of convertible debentures/bonds/securities through global depository receipts.
28 Jan 2004 Quarterly Results -
21 Oct 2003 Quarterly Results (Revised)
30 Sep 2003 Others To consider early closure of Buy Back programme of the Company through the Stock Exchange route before its normal validity period.
28 Jul 2003 Quarterly Results -
03 May 2003 Dividend & Accounts -
30 Jan 2003 Quarterly Results -
20 Dec 2002 Others Fix record date for stock split of shares.